Some determinants of camptothecin responsiveness in leukemia L1210 cells.
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002460:Cell Line / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D066298:In Vitro Techniques; D007930:Leucine / Q000378:metabolism; D007939:Leukemia L1210 / Q000378:metabolism*; D008297:Male; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D000470:Alkaloids; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D003609:Dactinomycin; D007930:Leucine; D013936:Thymidine; D014529:Uridine